Briviact (brivaracetam): Reviews and patient testimonials
Medication indications
Briviact 10 mg/ml oral solution
Briviact is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent patients from 16 years of age with epilepsy.
Briviact 10 mg/ml solution for injection/infusion
Briviact is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent patients from 16 years of age with epilepsy.
Briviact film-coated tablets
Briviact is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent patients from 16 years of age with epilepsy.
Route of administration: Injectable, Oral
Molecule: brivaracetam
Patients' opinions on Briviact
In brief
General satisfaction level: 6.40/10 Learn more
Treatment's effectiveness: 7.80/10 Learn more
Ease of use: 8.40/10 Learn more
Adherence to prescription: 8.40/10 Learn more
Detected side effects: 3.20/10 Learn more
Improvement in the quality of life: 5.60/10 Learn more
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community